HER2 mutations in Chinese patients with non-small cell lung cancer

BACKGROUND: ERBB2 (HER2) is a driver gene identified in non-small cell lung cancer (NSCLC). The prevalence, clinicopathology, genetic variability and treatment of HER2-positive NSCLC in Chinese population are unclear. PATIENTS AND METHODS: Eight hundred and fifty-nine patients with pathologically co...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zhengbo, Yu, Xinmin, Shi, Zhiyong, Zhao, Jun, Zhang, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363651/
https://www.ncbi.nlm.nih.gov/pubmed/27825109
http://dx.doi.org/10.18632/oncotarget.11313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363651/
https://www.ncbi.nlm.nih.gov/pubmed/27825109
http://dx.doi.org/10.18632/oncotarget.11313

Ejemplares similares